Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorder
Crossref DOI link: https://doi.org/10.1007/s00406-024-01851-7
Published Online: 2024-07-06
Published Print: 2025-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Demyttenaere, Koen https://orcid.org/0000-0001-5331-487X
Text and Data Mining valid from 2024-07-06
Version of Record valid from 2024-07-06
Article History
Received: 25 April 2024
Accepted: 17 June 2024
First Online: 6 July 2024
Declarations
:
: Advisory board / speakers bureau for: Boehringer-Ingelheim, JNJ, LivaNova, Lundbeck.